Ascentage Pharma Group International AAPG
NASDAQ AAPG
$15.05 -0.64 (-4.08%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ascentage Pharma Group International (AAPG) Non-Current Deffered Revenue (2023 - 2026)

Updated

Ascentage Pharma Group International (AAPG) recorded Non-Current Deffered Revenue of $925,219 in Q2 2026.

Analysis

Ascentage Pharma Group International (AAPG) Non-Current Deffered Revenue (2023 - 2026) Analysis & Trends

At the end of FY2025, Ascentage Pharma Group International reported Non-Current Deffered Revenue of $929,000, down 75.3% from FY2024.

  • Across earlier years, Non-Current Deffered Revenue came in at $3.77 million in FY2024 (-26.8%) and $5.15 million in FY2023.
  • The Q2 2026 figure is the highest quarterly Non-Current Deffered Revenue since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Ascentage Pharma Group International 1.46 Bn 432.82 Mn - 925,219.24
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 925,219.24
Dec 31, 2025 916,451.90
Dec 31, 2024 3.83 Mn
Dec 31, 2023 5.05 Mn
API Access

Ascentage Pharma Group International Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=AAPG&period=max&api_key=YOUR_API_KEY